ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Issell To Retire As Hawaii Center Director; M.D. Anderson honors LeMaistre, Faculty

November 8, 1996

In Brief: Benacerraf, Snell, Dausset Win Nobel Prize; AACE Seeks Increase In Clinical Education Funds

October 17, 1980

Wynder Group Finds No Association Between Coffee, Pancreatic Cancer

August 19, 1983

Genetic Risk Factor Implicated In Prostate Cancer In Blacks

August 25, 2006

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014